Literature DB >> 6420241

Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis.

T Poralla, T H Hütteroth, K H Meyer zum Büschenfelde.   

Abstract

In a microcytotoxicity assay we tested lymphocyte cytotoxicity against autologous hepatocytes. The following cytotoxicity values were found (given mean +/- SEM): acute non-A, non-B (NANB) hepatitis 45.7 +/- 4.3% (n = 7), chronic NANB hepatitis 32.8 +/- 5.1% (n = 11), chronic active hepatitis B (CAH-B) 27.7 +/- 6.7% (n = 10), toxic lesions 18.1 +/- 4.2% (n = 18), controls with normal liver histology or minimal changes 4.9 +/- 2.5% (n = 8). Thus our study shows enhanced cellular cytotoxicity in acute and chronic NANB hepatitis and indicates that T cells as well as non-T cells have cytotoxic effector functions. These findings are similar to those obtained in CAH-B and suggest that cellular immune reactions play an important role in the course of NANB hepatitis. For comparison we tested cytotoxic reactions in toxic lesions. They were only moderate and well distinguishable from those observed in NANB hepatitis and CAH-B; they even may be unspecific. No correlation was seen between cytotoxicity and aminotransferase concentrations.

Entities:  

Mesh:

Year:  1984        PMID: 6420241      PMCID: PMC1432252          DOI: 10.1136/gut.25.2.114

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

Authors:  N El Sheikh; C G Osman; H Cullens; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  H D Kay; G D Bonnard; W H West; R B Herberman
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.

Authors:  J L Dienstag; A K Bhan
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases.

Authors:  A Facchini; G F Stefanini; M Bernardi; F Miglio; G Gasbarrini; G Labö
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

6.  Cell-mediated cytotoxicity for cultured autologous rheumatoid synovial membrane cells.

Authors:  W A Neill
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

7.  Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.

Authors:  A M Cochrane; A Moussouros; A Smith; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

8.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.

Authors:  G M Vergani; D Vergani; P J Jenkins; B Portmann; A P Mowat; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

9.  Cell-mediated cytotoxicity in chronic active liver disease: a new test system.

Authors:  A J Vogten; N Hadzic; R G Shorter; W H Summerskill; W F Taylor
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

10.  HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2.

Authors:  A McMichael
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

Authors:  A Nicole; O Spertini; D Lavanchy; P C Frei
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

3.  Cellular cytotoxicity against autologous hepatocytes in children with different forms of chronic hepatitis B.

Authors:  K M Keller; T Poralla; H P Dienes; S Wirth; W Baumann
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

4.  Lymphocyte cytotoxicity for autologous hepatocytes.

Authors:  M Mondelli; A L Eddleston
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.

Authors:  M G Ghany; T M Chan; R Sanchez-Pescador; M Urdea; A S Lok
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

6.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis.

Authors:  T Takehara; N Hayashi; K Katayama; A Kasahara; H Fusamoto; M Kato; M Masuzawa; T Kamada
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.